关键词：银屑病关节炎；慢性炎症性疾病；远侧关节；骶髂关节；骨盆
摘 要：Psoriatic arthritis is a chronic inflammatory disease in which a person has both arthritis and psoriasis. It affects the joints in the body, mainly the distal joints of the fingers and toes, as well as lower extremities. It can also affect the back and sacroiliac joints of the pelvis. Psoriatic arthritis mostly occurs in people aged between 30 to 50 years old, but it can also be seen in children and adolescents. Both women and men are affected by psoriatic arthritis.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Product profiles

PART 04: Market research methodology

Research methodology

Economic indicators

PART 05: Introduction

Key market highlights

PART 06: Disease overview

Understanding the disease

Types of psoriatic arthritis

Symptoms

Risk factors

Diagnosis

Disease management

Quality of life

Epidemiology

PART 07: Pipeline portfolio

PART 08: Novel mechanisms targeted by pipeline

candidates

Small molecules

Biologics

PART 09: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 10: Market segmentation by MoA

TNF-alpha inhibitors

PDE4 inhibitors

IL blockers

Others

PART 11: Market segmentation by type of molecule

Biologics

Small molecules

PART 12: Market segmentation by severity of disease

PART 13: Market segmentation by route of

administration

Oral

Parenteral

Topical

PART 14: Market segmentation by dosage form

Solid

Liquid

Semi-solid

PART 15: Geographical segmentation

Psoriatic arthritis market in Americas

Psoriatic arthritis market in EMEA

Psoriatic arthritis market in APAC

PART 16: Market drivers

Increase in public awareness

Unmet medical needs

Growing patient population

Change in lifestyle patterns

PART 17: Impact of drivers

PART 18: Market challenges

Increasing costs of biologics

Loss of patent exclusivity of branded therapies

Use of CAM by patients

Adverse effects of drugs

PART 19: Impact of drivers and challenges

PART 20: Market trends

Emergence of biosimilars

Popularity of off-label and traditional treatment options

Patient assistance programs in the US

Dominance of market by biologics

PART 21: Vendor landscape

Competitive scenario

Market share analysis 2014

Other prominent vendors

PART 22: Key vendor analysis

AbbVie

Amgen

Celgene

Janssen Pharmaceuticals

UCB

PART 23: Appendix

List of abbreviations

PART 24: Explore Technavio